Atreca, a US-based immune-focused medicine developer based on research at Stanford University, completed an oversubscribed $125m series C round today led by an undisclosed existing investor described as a healthcare-focused fund.
The round included Tavistock Group’s Boxer Capital unit, Wellington Management Company, Cormorant Asset Management, Aisling Capital, EcoR1 Capital, Redmile Group, Samsara BioCapital and funds managed by Tekla Capital Management.
Atreca is developing drugs based on the responsiveness of the human body’s immune system. Its lead program is focused on cancer and its lead candidate, ATRC-101, is being developed to target breast, lung and colon tumours.
The company was co-founded by Lawrence Steinman, the George Zimmermann professor of neurology and neurological sciences and paediatrics in Stanford University’s School of Medicine.
John Orwin, Atreca’s president and chief executive, said: “This funding enables us to broaden and accelerate our discovery and pipeline generation efforts and to move our…
Atreca carries on funding streak
Sep 12, 2018 •
LEADERSHIP SOCIETY
Informing, connecting, and transforming the global corporate venture capital ecosystem.The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
University of Notre Dame tries new, supersized approach to creating spinouts
University of Notre Dame tries new, supersized approach to creating spinouts
A new $35m fund will be managed by external venture studio High Alpha Innovation and will work with the university on creating new startups.
How Basel supercharged its spinout rate
How Basel supercharged its spinout rate
Basel has quietly built a life sciences ecosystem that’s becoming hard to ignore.
Crumbling system, fragile lives: can spinouts help in the senior care crisis?
Crumbling system, fragile lives: can spinouts help in the senior care crisis?
From a chest-worn device to help with Parkinson's symptoms to stress measuring socks — here are the spinouts providing support for senior citizens.
Events
GCV Institute: Landing the Value of Corporate Venturing
May 6 -
May 9, 2024
Online
May 9, 2024
Online
Events
Webinar: CVCs and the art of the follow-on
May 8, 2024
Online
Online
Events
GCV Institute: CVC Investment Programs
May 21 -
May 22, 2024
Online
May 22, 2024
Online
Events
GCV Symposium 2024
Jun 24 -
Jun 26, 2024
London (UK)
Jun 26, 2024
London (UK)
Events
Corporate Venture in Brasil 2024 – International Delegation to Brazil
Oct 28 -
Oct 30, 2024
São Paulo (Brazil)
Oct 30, 2024
São Paulo (Brazil)
Top News
test reg